SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Labwire Inc.
LBWR 0.00010000.0%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: creede who wrote (813)5/10/2008 5:47:10 AM
From: shortsinthesand  Read Replies (2) of 1698
 
[LBWR]: Labwire, Inc. Securities Counsel David B. Stocker and several LBWR Reg D Rule 504 investors charged with Securities Fraud by the SEC

.

1. In a form 15c2-11 filed with pinksheets.com by Labwire, Inc. (LBWR), the company listed Arizona attorney David B. Stocker as its Securities Counsel:

snipurl.com

.

2. In addition, the LBWR form 15c2-11 includes an opinion letter written by Mr. Stocker stating that 1.8 million shares of LBWR stock issued under Reg. D Rule 504 would be exempt from the SEC registration requirements and therefore can be freely trading.

.

3. In the same LBWR form 15c2-11, Labwire, Inc. states that Mr. Stocker "does not own any shares of the issuer".

.

4. The form 15c2-11 also includes an Exhibit "A", which lists the purchasers of the 1.8 million LBWR shares.

.

5. Among the fourteen "purchasers" listed in Exhibit "A" are:

Curtis-Case, Inc. - 250,000 shares

Page Properties, LP - 250,000 shares

Janan Page - 100,000 shares

Trevor Page - 100,000 shares

Martin Cantu - 100,000 shares

.

6. The Securities Exchange Commission charged certain individuals and entities with Securities Fraud in the sale of unregistered securities in Litigation Release No. 20302 dated September 27, 2007: sec.gov

.

7. Among the defendants in the SEC securities fraud litigation release mentioned in the above paragraph are:

- David B. Stocker, LBWR's Securities Counsel mentioned in paragraphs 1, 2 and 3 above.

- Page Properties, LP, an LBWR Rule 504 purchaser mentioned in paragraph 5 above.

- Curtis-Case, Inc., an LBWR Rule 504 purchaser mentioned in paragraph 5 above.

.

8. According to the SEC Litigation Release, Page Properties, LP is controlled by Timothy T. Page, another Defenant in the SEC securities fraud case.

.

9. Janan Page, an LBWR Rule 504 purchaser mentioned in paragraph 5 above, is listed as Timothy T. Page's spouse in the following SEC filing: secinfo.com

.

10. It is believed that Trevor Page, an LBWR Rule 504 purchaser mentioned in paragraph 5 above, is related to Timothy T. Page and/or Janan Page.

.

11. Martin Cantu, an LBWR Rule 504 purchaser mentioned in paragraph 5 above, is listed as a significant stockholder and Director of a company that is controlled by Timothy T. Page, Lion Capital Holdings, Inc.: secinfo.com

.

12. According to the SEC Litigation Release, Curtis-Case, Inc., an LBWR Rule 504 purchaser mentioned in paragraph 5 above and a defendant in the SEC Securities Fraud case is controlled by LBWR Securities Counsel David B. Stocker. As discussed in the paragraph 3 above, the LBWR form 15c2-11 had specifically stated that Mr. Stocker "does not own any shares of the issuer", which seems to contradict the information stated in the SEC Litigation Release discussed above.

.

13. Martin Cantu, LBWR's significant stockholder mentioned above is further discussed in this article by award winning journalist Carol S. Remond, in a Dow Jones Newswires Column:

snipurl.com

.

14. What does all of the above say about the quality of management of Labwire, Inc.?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext